Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • American diplomat Henry Kissinger dies aged 100
    • Eurozone inflation falls more than expected to 2.4%
    • UAE to launch $30bn investment fund at COP28
    • US accuses Indian official in foiled plot to kill Sikh separatist in New York City
    • Opec+ production cuts leave oil market sceptical
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • EY pushes some graduate start dates back by almost a year
      • Warren Buffett followers contemplate Berkshire Hathaway without Charlie Munger
      • Global bank executives hit out at US capital plans
      • VMware’s $92bn sale showers cash on Michael Dell and Silver Lake
      • Vail agrees to buy Switzerland’s Crans-Montana ski resort in $136mn deal
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • News updates from November 30: Global stocks record best month in 3 years on rate cut hopes, US oil production rises to fresh record
      • Eurozone inflation falls more than expected to 2.4%
      • Opec+ production cuts leave oil market sceptical
      • Global stocks record best month in three years on interest rate cut hopes
      • Global bank executives hit out at US capital plans
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • War has spread to a sixth domain: the private sector
      • The Nikki Haley wild card for 2024
      • The fading era of hyperglobalisation is a study in success
      • How Godzilla became Japan’s most put-upon worker
      • The US retains the economic advantage in its rivalry with China
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
      Most Read
      • ‘Double dipping’: why managers worry that staff have a second job on the sly
      • Desks by the hour: why flexible offices are a hit with business
      • Should I switch non-profit work for the corporate world?
      • Property boss David Sleath gives warehouses the hard sell
      • The people defending humanity from AI can’t even write a decent press release
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The FT’s 25 most influential women of 2023
      • How I got from Gatwick to Rome — on an invalid passport
      • Buyers are drawn to Walthamstow, where East End meets high end
      • The Aman look comes home
      • The world’s best Christmas markets
    • HTSI
    1. Companies
    2. Health
    • Healthcare
    • Pharmaceuticals
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Health

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Thursday, 30 November, 2023
      Genomics
      Britain’s genetic databank to unveil largest-ever sequencing release

      ‘Treasure trove’ will be used to develop drugs and treatments for wide range of diseases and is culmination of 20 years of work

      Technicians in a laboratory
    • Wednesday, 29 November, 2023
      Ageing Populations
      Science prize targets health advances for ageing societies

      Non-profit offers $101mn for discoveries that will restore muscle, brain and immune functions

      An elderly Chinese man on a bicycle
    • Wednesday, 29 November, 2023
      HTSI
      Can you change your health fate?

      Diagnostic testing flags up a huge range of issues — both lifestyle and hereditary. So, what do you want to know?

    • Tuesday, 28 November, 2023
      Style
      Holiday gift guide 2023

      Charlie McCormick, Aurora James, Antwaun Sargent and more share their holiday plans and present ideas for the season

    • Tuesday, 28 November, 2023
      National Health Service
      NHS cancer services buckling, warns leading charity

      Cancer Research UK report says UK government must invest in staffing and funding for research

    • Tuesday, 28 November, 2023
      Mental health
      Internet use does not appear to harm mental health, study finds

      No evidence to support ‘popular ideas that certain groups are more at risk’, according to researchers

      A girl texting on a smartphone
    • Monday, 27 November, 2023
      Alice Gast
      Rare cancers need a Silicon Valley approach to investment

      Innovative models can drive funding for research on neglected, less survivable diseases

      Protein analysis tubes are seen in a lab at the Institute of Cancer Research in Sutton
    • Monday, 27 November, 2023
      FT News Briefing podcast11 min listen
      COP28: Climate summit tries to kick fossil fuel habit

      Turkey’s exports to Russia of goods vital for Moscow’s war machine have soared this year

    • Monday, 27 November, 2023
      Novo Nordisk AS
      Novo Nordisk looks at flexible pricing for obesity drug

      Danish pharma group in talks with healthcare providers about innovative models to boost Wegovy take-up

      Lars Fruergaard Jørgensen
    • Sunday, 26 November, 2023
      Healthcare costs
      How the boom in private medical insurance is exposing its own flaws

      Demand is soaring thanks to the NHS crisis, but providers are up against inflation and fierce competition for doctors

      Ryan Corwood, an operation department practitioner, prepares an operating theatre at the BMI Weymouth hospital in London
    • Sunday, 26 November, 2023
      InterviewBayer AG
      Bayer chief blames thin drug pipeline on ‘years of under-investment’

      Bill Anderson says group is generating a series of promising new drugs after R&D strategy change

      Bill Anderson
    • Thursday, 23 November, 2023
      Disease control and prevention
      WHO asks China for data on ‘undiagnosed pneumonia’ cases

      Health body’s concern reflects heightened vigilance over signs of disease outbreaks since Covid pandemic

      Children and their parents wait to be seen at a children’s hospital in Beijing
    • Wednesday, 22 November, 2023
      AstraZeneca PLC
      AstraZeneca fights accusations its Covid-19 jab was ‘defective’

      Vaccine recipient claims he suffered side effect of severe blood clot

      A health worker prepares a dose of the AstraZeneca Covid-19 vaccine
    • Tuesday, 21 November, 2023
      Autumn Statement
      Benefits recipients fear financial squeeze of chancellor’s welfare reforms

      Claimants previously assessed as too sick for a job worried they could be told to work from home

      Michael Robinson
    • Monday, 20 November, 2023
      Bayer AG
      Bayer shares plunge after blood-thinning drug trial halted

      German group says prospective blockbuster asundexian failed to demonstrate efficacy

      The Bayer logo
    • Monday, 20 November, 2023
      Europe Express
      EU countries warn of health risks caused by climate change Premium content

      Also in this newsletter: Why tourists and residents are fighting over Rome’s sidewalks

      Street thermometer displays 42 degrees Celsius
    • Monday, 20 November, 2023
      Rana Foroohar
      Behold the Ozempic effect on business

      A new crop of weight-loss drugs is disrupting markets as well as transforming waistlines

      An illustration of a bottle of pills with a shadow taking shape as a bag of dollars
    • Sunday, 19 November, 2023
      Joanne Liu
      Patients and doctors must never become targets of war

      In any conflict situation, from Gaza to Ukraine, medical staff must be protected and given unhindered access to patients

    • Sunday, 19 November, 2023
      GP staff in England warn many buildings ‘not fit for purpose’

      Royal College of GPs urges government to take action over ‘unsafe’ infrastructure ahead of Autumn Statement

      A GP at work
    • Saturday, 18 November, 2023
      Ella Risbridger
      Can you keep a secret? Try, it’s good for you

      In the age of the like, the share and the overshare, enjoy the quiet glee of hanging on to good news

      A picture of a forest. If a tree falls in a forest and nobody posts a leaf-strewn, autumnal image on Instagram, did it really happen?
    • Thursday, 16 November, 2023
      Autumn Statement
      UK to spend £2.5bn on employment support

      Chancellor to announce plans to tackle long-term sickness and joblessness in Autumn Statement next week

      Commuters cross London Bridge, during Storm Ciaran
    • Thursday, 16 November, 2023
      Artificial intelligence
      AI boosts breast cancer detection rates, new research shows

      Study shows potential of technology to improve and speed up medical diagnoses

      Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma: AI analysis flagged up to 13 per cent more cases than doctors had identified
    • Thursday, 16 November, 2023
      Medical science
      UK approves Crispr gene editing therapy in global first

      Regulator authorises treatment for sickle cell disease and beta thalassaemia

      A scientist at Vertex Pharmaceuticals
    • Wednesday, 15 November, 2023
      Working It
      Your wellbeing plans don’t work

      Why it may be time to ditch the apps and meditation zones — plus the Office Therapy advice column

      Three people looking miserable
    • Wednesday, 15 November, 2023
      Biotech
      Biotech raises funds to find cancer treatments using transgenic mice

      T-Therapeutics hopes to use genetically engineered rodents and machine learning to discover drugs

      Allan Bradley, founder of T-Therapeutics
    Previous page You are on page 1 Next page

    Join us at an FT Live event

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    Accelerating Access to Cancer Care In Europe
    Leveraging public private partnerships to improve treatment speed and prevention
    Monday, 11 DecemberHotel Sofitel Brussels Europe, Place Jourdan 1, 1040 Bruxelles, Belgique
    FT Live
    The Future of People-Centred Health Innovation
    Exploring policies and priorities for adopting new innovations into health systems
    Monday, 22 January 2024Digital Conference
    FT Live
    US Pharma and Biotech Summit
    Strategies for innovation, pricing and access
    Thursday, 16 May 2024New York, NY, USA
    Explore all events

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Israel-Hamas war
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
      • Artificial intelligence
      • Semiconductors
      • Cyber Security
      • Social Media
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today’s Newspaper (FT Digital Edition)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In